Our data collectively suggest that AZD0530 reverses the LIF-associated cancer invasive phenotype, at least partly, by increasing cytoplasmic YAP1 and suppressing expression of the focal adhesion components p-PXN and p-FAK. The gene discussed is PTK2; the disease is cancer.